Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,423.10
+16.90 (1.20%)
Jun 15, 2026, 3:29 PM IST
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 4.3 billion as of June 15, 2026. Its market cap has increased by 4.63% in one year.
Market Cap
4.30B
Enterprise Value
5.54B
Revenue
3.34B
Ranking
n/a
PE Ratio
24.85
Stock Price
1,423.10
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 4.30B, an increase of 955.32%. That is a compound annual growth rate of 30.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 4.30B | 7.48% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 678.10B |
| Anthem Biosciences | 442.94B |
| OneSource Specialty Pharma | 184.87B |
| Concord Biotech | 141.63B |
| Blue Jet Healthcare | 88.90B |
| Supriya Lifescience | 78.64B |
| Zota Health Care | 42.43B |
| Panacea Biotec | 32.83B |